Contact Address

#B-1 & B-2, KSSIDC, Veerasandra Industrial Area Stage 1, Electronic City Phase 2, Bengaluru - 560100, Karnataka, India

Contact Info

MALDI Biotyper: Rapid Microbial & Proteomic Profiling

MALDI Biotyper: Rapid Microbial & Proteomic Profiling

As therapeutic modalities scale and evolve, traditional, labor-intensive biochemical assays are no longer sufficient to maintain rigorous production timelines. We utilize the Bruker MALDI Biotyper®, an industry-leading system based on MALDI-TOF mass spectrometry to provide rapid, unbiased microbial identification down to the species level within minutes. By determining the unique proteomic fingerprint of unknown microorganisms and matching it against an extensive reference library, we ensure unparalleled precision and traceability for your most critical manufacturing processes.

Our advanced capabilities support the following critical applications:

Rapid Microbial Identification:

This approach replaces slow traditional assays with high-throughput molecular fingerprinting. It delivers accurate, in-house identification of demanding microorganisms, including anaerobic bacteria and fungi, in a fraction of the time.

Environmental Monitoring & Isolate Identification:

The system enables definitive surveillance of manufacturing facilities by providing rapid, unbiased identification of isolates down to the species level.

Contamination Source Identification:

Tracking facility contaminants relies on comparing unknown organisms to a ready-to-use reference library covering thousands of species. This rapid identification translates to high cost savings by preventing costly production line downtime and lost product shipments.

Sterility Testing Support:

The system provides a rapid, highly accurate solution for identifying microbial isolates. This speed accelerates actionable decision-making and root-cause analysis in time-critical scenarios.

Microbial Quality Control for Cell & Gene Therapy Manufacturing:

The platform supports complete workflow traceability and regulatory compliance. This rigorous compliance is crucial for managing the short shelf-life and unique safety requirements of live biotherapeutics, T-cell therapies, and non-viral gene delivery systems.